is glp 1 safe for breast cancer survivors GLP-1 Receptor Agonists in Cancer: A New Frontier in Obesity and Prognosis Management Ending Breast Cancer Forever |

JourneyLite patients can explore: Medical weight loss programs GLP-1 medications and alternatives Gastric sleeve surgery Gastric bypass surgery SADI surgery Revision bariatric surgery Gastric balloon options Dietitian support and long-term follow-up This matters because obesity treatment is not one-size-fits-all

Hatfield DL, Gladyshev VN

If you experience inadequate response after 1216 weeks at a therapeutic maintenance dose (typically 1015 mg weekly) despite good adherence and lifestyle modifications, consult your healthcare provider to assess for secondary causes, verify proper administration technique, and consider dose optimization or alternative treatment strategies

It is critical to seek appropriate treatment if this situation applies to you

Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR

If your provider can use a non-systemic option for your condition, that may avoid the interaction entirely